Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors.

Frahm N, Hecker M, Zettl UK.

Sci Rep. 2019 Mar 6;9(1):3743. doi: 10.1038/s41598-019-40283-5.

2.

Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.

Frahm N, Hecker M, Zettl UK.

PLoS One. 2019 Jan 24;14(1):e0211120. doi: 10.1371/journal.pone.0211120. eCollection 2019.

3.

Polypharmacy in patients with multiple sclerosis: a gender-specific analysis.

Frahm N, Hecker M, Zettl UK.

Biol Sex Differ. 2019 May 27;10(1):27. doi: 10.1186/s13293-019-0243-9.

4.

Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer.

Calip GS, Xing S, Jun DH, Lee WJ, Hoskins KF, Ko NY.

J Oncol Pract. 2017 May;13(5):e451-e462. doi: 10.1200/JOP.2016.018317. Epub 2017 Mar 13.

PMID:
28287854
5.

Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.

Cantudo-Cuenca MR, Jiménez-Galán R, Almeida-Gonzalez CV, Morillo-Verdugo R.

J Manag Care Spec Pharm. 2014 Aug;20(8):844-50.

6.

Drug adherence and multidisciplinary care in patients with multiple sclerosis: protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study).

Jongen PJ, Hengstman G, Hupperts R, Schrijver H, Gilhuis J, Vliegen JH, Hoogervorst E, van Huizen M, van Munster E, Samijn J, de Schryver E, Siepman T, Tonk M, Zandbergen E, ten Holter J, van der Kruijk R, Borm G.

BMC Neurol. 2011 Mar 30;11:40. doi: 10.1186/1471-2377-11-40.

7.

Non-adherence to antihypertensive medication: The role of mental and physical comorbidity.

Calderón-Larrañaga A, Diaz E, Poblador-Plou B, Gimeno-Feliu LA, Abad-Díez JM, Prados-Torres A.

Int J Cardiol. 2016 Mar 15;207:310-6. doi: 10.1016/j.ijcard.2016.01.069. Epub 2016 Jan 11.

PMID:
26814635
8.

[Drug prescription profile in patients with advanced chronic diseases].

Ramírez-Duque N, Rivas-Cobas C, Bernabeu-Wittel M, Ruiz-Cantero A, Murcia-Zaragoza J, Oliver M, Díez-Manglano J; en representación de los investigadores del proyecto PALIAR.

Rev Esp Geriatr Gerontol. 2014 Nov-Dec;49(6):255-9. doi: 10.1016/j.regg.2014.01.006. Epub 2014 Mar 13. Spanish.

PMID:
24629732
9.

Medication prescription among elderly patients admitted through an acute assessment unit.

Yong TY, Lau SY, Li JY, Hakendorf P, Thompson CH.

Geriatr Gerontol Int. 2012 Jan;12(1):93-101. doi: 10.1111/j.1447-0594.2011.00737.x. Epub 2011 Sep 19.

PMID:
21929721
10.

Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional Study.

Akbarov A, Kontopantelis E, Sperrin M, Stocks SJ, Williams R, Rodgers S, Avery A, Buchan I, Ashcroft DM.

Drug Saf. 2015 Jul;38(7):671-82. doi: 10.1007/s40264-015-0304-x.

11.

Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.

Chitty KM, Evans E, Torr JJ, Iacono T, Brodaty H, Sachdev P, Trollor JN.

Aust N Z J Psychiatry. 2016 Apr;50(4):352-62. doi: 10.1177/0004867415587951. Epub 2015 May 27.

PMID:
26019276
12.

Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.

Hanlon P, Nicholl BI, Jani BD, McQueenie R, Lee D, Gallacher KI, Mair FS.

BMJ Open. 2018 Jan 14;8(1):e018404. doi: 10.1136/bmjopen-2017-018404.

13.

Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.

Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA.

Am J Geriatr Pharmacother. 2010 Feb;8(1):63-72. doi: 10.1016/j.amjopharm.2010.01.001.

PMID:
20226393
14.

Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.

Negewo NA, Gibson PG, Wark PA, Simpson JL, McDonald VM.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 6;12:2929-2942. doi: 10.2147/COPD.S136256. eCollection 2017.

15.

Prevalence and Factors Associated With Polypharmacy Use Among Adult Patients in Saudi Arabia.

Balkhi B, AlQahtani N, Alwhaibi M, Alshammari TM, Alhawassi TM, Mahmoud MA, Almetwazi M, Ata S, Basyoni M, Aljadhey H.

J Patient Saf. 2017 Oct 30. doi: 10.1097/PTS.0000000000000439. [Epub ahead of print]

PMID:
29087978
16.

Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study.

Sato I, Akazawa M.

Drug Healthc Patient Saf. 2013 Jun 24;5:143-50. doi: 10.2147/DHPS.S45347. Print 2013.

17.

Multiple medication use in older patients in post-acute transitional care: a prospective cohort study.

Runganga M, Peel NM, Hubbard RE.

Clin Interv Aging. 2014 Sep 2;9:1453-62. doi: 10.2147/CIA.S64105. eCollection 2014.

18.

Drug therapy problems and medication discrepancies during care transitions in super-utilizers.

Surbhi S, Munshi KD, Bell PC, Bailey JE.

J Am Pharm Assoc (2003). 2016 Nov - Dec;56(6):633-642.e1. doi: 10.1016/j.japh.2016.07.004. Epub 2016 Oct 6.

PMID:
27720595
19.

Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.

Fontanella CA, Bridge JA, Campo JV.

Ann Pharmacother. 2009 Dec;43(12):1939-47. doi: 10.1345/aph.1M326. Epub 2009 Nov 24.

PMID:
19934394
20.

General practitioners' views on polypharmacy and its consequences for patient health care.

Köberlein J, Gottschall M, Czarnecki K, Thomas A, Bergmann A, Voigt K.

BMC Fam Pract. 2013 Aug 15;14:119. doi: 10.1186/1471-2296-14-119.

Supplemental Content

Support Center